Premium
Nitric oxide‐dependent relaxation induced by M 1 muscarinic receptor activation in the rat small intestine
Author(s) -
Olgart C,
Iversen H H
Publication year - 1999
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702529
Subject(s) - muscarinic acetylcholine receptor , muscarinic acetylcholine receptor m1 , chemistry , endocrinology , hexamethonium , muscarinic acetylcholine receptor m3 , medicine , muscarinic acetylcholine receptor m2 , guanethidine , agonist , nitric oxide synthase , nitric oxide , receptor , acetylcholine , pharmacology , biology , biochemistry , stimulation
The aim of the present study was to investigate whether muscarinic M 1 receptor activation induces intestinal relaxation via nerve‐dependent nitric oxide formation. Mechanical activity in longitudinal segments of rat jejunum was recorded isotonically in organ baths. The muscarinic M 1 receptor agonist 4‐[[[(3‐Chlorophenyl)amino]carbonyl]oxy]‐N,N,N,‐trimethyl‐2‐butyn‐1‐amonium chloride (McN‐A‐343, 10 −7 –10 −4 M ) induced a concentration‐dependent relaxation of rat jejunum. Relaxations induced by McN‐A‐343 (10 −5 M ) were inhibited by the M 1 receptor antagonist telenzepine (10 −8 M ), and enhanced by the M 3 receptor antagonist para‐fluoro‐hexahydrosiladifenidol (p‐F‐HHSiD; 3×10 −7 M ). The inhibitory responses induced by McN‐A‐343 were abolished by the nitric oxide synthase inhibitors N ω ‐nitro‐ L ‐arginine ( L ‐NOARG; 10 −4 M ) and N ω ‐monomethyl‐ L ‐arginine ( L ‐NMMA; 3×10 −5 M ), the guanylyl cyclase inhibitor 1H‐[1,2,4]oxadiazolo[4,3,‐a]quinoxalin‐1‐one (ODQ; 10 −5 M ), and by tetrodotoxin (TTX; 3×10 −7 M ). Guanethidine or hexamethonium did not affect inhibitory responses induced by McN‐A‐343. In conclusion, McN‐A‐343 induces nerve‐dependent, nitrergic relaxations in rat jejunum, via activation of muscarinic M 1 receptors. Hence, selective muscarinic M 1 receptor agonists or antagonists might offer possibilities for pharmacological manipulation of the NO system.British Journal of Pharmacology (1999) 127 , 309–313; doi: 10.1038/sj.bjp.0702529